The Optimality of Different Strategies for Supplemental Staging of Non–Small-Cell Lung Cancer: A Health Economic Decision Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.09.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Staging Non-Small Cell Lung Cancer

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2007English

Cost-Benefit of Minimally Invasive Staging of Non-Small Cell Lung Cancer: A Decision Tree Sensitivity Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Minimally Invasive Mediastinal Staging of Non-Small Cell Lung Cancer

Precision and Future Medicine
2018English

Optimal Sequence of Tests for the Mediastinal Staging of Non-Small Cell Lung Cancer

BMC Medical Informatics and Decision Making
Health PolicyHealth Informatics
2016English

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Thoroughness of Mediastinal Staging in Stage IIIA Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

The Practice of Cardiothoracic Surgeons in the Perioperative Staging of Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1992English

The Accuracy of Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer

Turkish Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2013English

Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy